Enovis Corp. (ENOV)
24.90
+0.07
(+0.28%)
USD |
NYSE |
Aug 28, 16:00
24.87
-0.03
(-0.12%)
After-Hours: 20:00
Enovis Free Cash Flow : 63.66M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | 63.66M |
| March 31, 2026 | 35.92M |
| December 31, 2025 | 19.92M |
| September 30, 2025 | 22.76M |
| June 30, 2025 | -3.952M |
| March 31, 2025 | -38.98M |
| December 31, 2024 | -67.21M |
| September 30, 2024 | -61.88M |
| June 30, 2024 | -60.26M |
| March 31, 2024 | -37.33M |
| December 31, 2023 | 12.76M |
| September 30, 2023 | -100.45M |
| June 30, 2023 | -105.89M |
| March 31, 2023 | -145.78M |
| December 31, 2022 | -161.31M |
| September 30, 2022 | -23.00M |
| June 30, 2022 | 46.64M |
| March 31, 2022 | 153.50M |
| December 31, 2021 | 251.86M |
| September 30, 2021 | 281.89M |
| June 30, 2021 | 262.47M |
| March 31, 2021 | 221.88M |
| December 31, 2020 | 187.15M |
| September 30, 2020 | 131.73M |
| June 30, 2020 | 101.86M |
| Date | Value |
|---|---|
| March 31, 2020 | 127.31M |
| December 31, 2019 | 5.546M |
| September 30, 2019 | 61.53M |
| June 30, 2019 | 94.34M |
| March 31, 2019 | 73.83M |
| December 31, 2018 | 156.72M |
| September 30, 2018 | 116.52M |
| June 30, 2018 | 87.06M |
| March 31, 2018 | 107.56M |
| December 31, 2017 | 150.00M |
| September 30, 2017 | 217.58M |
| June 30, 2017 | 224.61M |
| March 31, 2017 | 212.29M |
| December 31, 2016 | 183.72M |
| September 30, 2016 | 174.71M |
| June 30, 2016 | 216.30M |
| March 31, 2016 | 247.27M |
| December 31, 2015 | 233.94M |
| September 30, 2015 | 281.35M |
| June 30, 2015 | 355.72M |
| March 31, 2015 | 370.83M |
| December 31, 2014 | 304.42M |
| September 30, 2014 | 297.23M |
| June 30, 2014 | 237.90M |
| March 31, 2014 | 242.45M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Intuitive Surgical, Inc. | 3.223B |
| STAAR Surgical Co. | -6.749M |
| Inspire Medical Systems, Inc. | 117.09M |
| Edwards Lifesciences Corp. | 1.434B |
| Kewaunee Scientific Corp. | 14.70M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 75.03M |
| Cash from Investing (Quarterly) | -45.01M |
| Cash from Financing (Quarterly) | -50.56M |
| Free Cash Flow Per Share (Quarterly) | 0.5406 |
| Free Cash Flow to Equity (Quarterly) | 72.61M |
| Free Cash Flow to Firm (Quarterly) | 28.56M |
| Free Cash Flow Yield | 4.46% |